Retatrutide

RETATRUTIDE (10mg) 

For laboratory research use only. Not for human consumption.

Key Benefits

• Supports research into appetite and satiety pathways
• Explores combined GLP-1, GIP & Glucagon receptor activation
• Investigates mechanisms behind metabolic rate and energy use
• Potential model for studying multi-pathway weight-management signalling
• Useful in studies related to fat-oxidation and energy expenditure
• Allows comparison against single-pathway incretin peptides (GLP-1 only)

Retatrutide is a next-generation peptide designed to support research into metabolism, appetite regulation, and energy expenditure. It belongs to a unique class of “triple agonist” peptides — meaning it interacts with three powerful metabolic receptors:

• GLP-1 receptor
• GIP receptor
• Glucagon receptor

This triple-pathway design is why Retatrutide has rapidly become one of the most studied peptides in metabolic research. Researchers are particularly interested in its potential role in body-weight regulation, reduced appetite signalling, and improved metabolic balance.

Retatrutide’s multi-receptor activity allows researchers to explore how combined GLP-1, GIP, and Glucagon receptor pathways may influence:

• Appetite and satiety signals
• Energy use and fat-oxidation
• Metabolic rate
• Digestive emptying speed
• Overall metabolic efficiency

Retatrutide is supplied as a lyophilised (freeze-dried) peptide powder in a sterile glass vial for precise, controlled laboratory experiments.

Product Details

• Quantity: 10mg lyophilised peptide powder
• Form: Sterile research-grade vial
• Storage: Refrigerate at 2–8°C. Short periods at room temperature during transit are acceptable.
• Reconstitution: Suitable laboratory-grade diluent (per researcher protocol).

Legal & Compliance

This product is supplied strictly for laboratory, scientific, and in-vitro research only.
Not for human use, medical use, diagnostic use, or veterinary use.
No health, therapeutic, or medical claims are made about this peptide.